Capsule and Topical Cream Treatments for Polyneuropathy
For polyneuropathy, gabapentin (oral capsule) is the first-line systemic treatment, typically titrated to 2400 mg/day in divided doses, while capsaicin 8% patch is the preferred topical treatment for localized neuropathic pain, applied for 30-60 minutes under medical supervision with effects lasting up to 12 weeks. 1, 2
First-Line Oral Treatment: Gabapentin
Gabapentin is recommended as the first-line oral pharmacological treatment for chronic neuropathic pain associated with polyneuropathy. 1
Dosing Strategy
- Start with low doses (100-200 mg/day) in older adults or those with renal impairment 1
- Titrate gradually to a typical target dose of 2400 mg/day in divided doses 1
- Effective doses in clinical trials range from 900-3600 mg/day in 2-3 divided doses, though older adults may respond to lower doses 1
- Allow adequate time between dose escalations to monitor for side effects 1
Expected Outcomes
- Gabapentin has a number needed to treat (NNT) of 4.1, meaning approximately 1 in 4 patients will achieve more than 50% pain relief 3
- Additionally improves sleep scores, with somnolence reported by 80% of patients 1
Common Side Effects
- Somnolence, dizziness, and mental clouding are common and particularly problematic in older patients 1
- Peripheral edema, weight gain, nausea, vertigo, and ataxia may occur 4
First-Line Topical Treatment: Capsaicin 8% Patch
Capsaicin 8% patch is strongly recommended as a topical treatment for chronic neuropathic pain with high-quality evidence, particularly effective for localized peripheral neuropathic pain. 1, 2
Application Protocol
- Pre-treatment is mandatory: Apply 4% topical lidocaine for 60 minutes before capsaicin application to reduce discomfort 1, 2
- Apply the 8% patch for 30-60 minutes to the most painful areas under medical supervision 1, 2
- A single application provides pain relief lasting up to 12 weeks 1, 2
- Treatment can be repeated every 90 days if pain returns 2
Expected Outcomes
- Approximately 31% of patients achieve >30% mean reduction in pain compared to 14% with placebo 1, 2
- Pain reduction is significant from the second week through 8-12 weeks after application 2
Managing Application Discomfort
- Consider prescribing short-acting opioids (such as hydrocodone with acetaminophen) or acetaminophen for use during and up to 7 days after application 2
- Common side effects include erythema, burning sensation, and application site pain, which are usually mild and transient 1, 2
Critical Safety Precautions
- Healthcare staff must wear gloves during the entire application process 2
- Warn patients to avoid contact with eyes, mucous membranes, and genitalia, as capsaicin is a potent local irritant 2, 5
Alternative Topical Treatment: Low-Concentration Capsaicin Cream
For patients who cannot access the 8% patch or prefer self-application, low-concentration capsaicin cream (0.025-0.075%) can be applied 3-4 times daily. 2, 6
FDA-Approved Dosing (Low-Concentration)
- Apply a thin film of cream to affected area and gently rub in until fully absorbed 6
- Unless treating hands, wash hands thoroughly with soap and water immediately after application 6
- Apply 3-4 times daily for best results 6
- Treatment duration of 6 weeks is typically needed to assess efficacy 2
Limitations
- Evidence for low-concentration capsaicin is more limited compared to the 8% patch 2, 5
- Initial stinging/burning sensation typically resolves with continued use 2
- NNT of 5.9, meaning it is less effective than high-concentration formulations 3
Second-Line Oral Treatments
If gabapentin provides inadequate response, consider tricyclic antidepressants (nortriptyline or desipramine) or serotonin-norepinephrine reuptake inhibitors (duloxetine or venlafaxine). 1
Tricyclic Antidepressants
- Secondary amines (nortriptyline, desipramine) are preferred over tertiary amines due to fewer anticholinergic side effects 1
- NNT of 2.6, making them highly effective but limited by tolerability 3
- Start with low doses at bedtime and titrate slowly 1
- Obtain screening ECG for patients over 40 years; use with caution in cardiac disease 1
- Allow 6-8 weeks for an adequate trial, including 2 weeks at the highest tolerated dose 1
SNRIs (Duloxetine, Venlafaxine)
- NNT of 6.7 for selective serotonin reuptake inhibitors 3
- Better tolerated than tricyclics but less effective 1
Combination Therapy Approach
For patients with partial response to monotherapy (pain remains ≥4/10), add a medication from a different class rather than switching. 1
Rational Combinations
- Gabapentin + capsaicin 8% patch for localized pain with systemic symptoms 1
- Gabapentin + tricyclic antidepressant for severe, refractory pain 1
Treatment Algorithm
Initial Assessment: Establish diagnosis of neuropathic polyneuropathy and identify any treatable underlying causes 1
First-Line Treatment:
Reassess at 4-6 Weeks:
Second-Line Options: If first-line treatments fail, consider tricyclic antidepressants or SNRIs 1
Refractory Cases: Refer to pain specialist or multidisciplinary pain center 1
Common Pitfalls to Avoid
- Do not skip lidocaine pre-treatment before capsaicin 8% patch application—this is the most critical step for tolerability 2
- Do not undertitrate gabapentin—many patients require 2400-3600 mg/day for adequate effect 1
- Do not expect immediate results—capsaicin effects begin at week 2, and gabapentin requires 4-6 weeks for full assessment 1, 2
- Do not use low-concentration capsaicin cream less than 3-4 times daily—frequency is crucial for efficacy 2, 6
- Do not use tricyclic antidepressants without cardiac screening in patients over 40 years 1